CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 195 filers reported holding CYTOKINETICS INC in Q1 2021. The put-call ratio across all filers is 0.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,328,244 | -27.6% | 112,975 | +12.6% | 0.05% | -29.2% |
| Q4 2022 | $4,598,220 | -20.9% | 100,354 | -16.4% | 0.07% | -10.0% |
| Q3 2022 | $5,816,000 | +64.5% | 120,000 | +33.3% | 0.08% | +63.3% |
| Q2 2022 | $3,536,000 | +60.1% | 90,000 | +50.0% | 0.05% | +88.5% |
| Q1 2022 | $2,208,000 | -19.2% | 60,000 | 0.0% | 0.03% | -13.3% |
| Q4 2021 | $2,734,000 | -47.2% | 60,000 | -58.6% | 0.03% | -49.2% |
| Q3 2021 | $5,182,000 | +468.8% | 145,000 | +215.2% | 0.06% | +391.7% |
| Q2 2021 | $911,000 | +35.0% | 46,000 | +41.5% | 0.01% | -20.0% |
| Q4 2020 | $675,000 | -96.2% | 32,500 | -96.0% | 0.02% | -96.4% |
| Q3 2020 | $17,568,000 | +1040.8% | 811,500 | +1142.7% | 0.41% | +705.9% |
| Q2 2020 | $1,540,000 | +213.0% | 65,300 | +56.5% | 0.05% | +82.1% |
| Q1 2020 | $492,000 | +200.0% | 41,736 | +189.8% | 0.03% | +211.1% |
| Q3 2019 | $164,000 | -51.3% | 14,400 | -52.0% | 0.01% | -47.1% |
| Q2 2019 | $337,000 | – | 30,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,723,170 | $13,940,000 | 5.01% |
| RP Management, LLC | 875,656 | $7,084,000 | 3.54% |
| BVF INC/IL | 3,801,817 | $30,757,000 | 3.44% |
| DAFNA Capital Management LLC | 400,294 | $3,238,000 | 1.40% |
| Virtus ETF Advisers LLC | 33,758 | $273,000 | 0.58% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 67,352 | $545,000 | 0.44% |
| WASATCH ADVISORS LP | 3,188,487 | $25,795,000 | 0.28% |
| LANSDOWNE PARTNERS (UK) LLP | 1,459,706 | $11,809,000 | 0.26% |
| Campbell & CO Investment Adviser LLC | 43,844 | $355,000 | 0.18% |
| Fosun International Ltd | 239,792 | $1,981,000 | 0.13% |